Evidence map›Paper›PMID 31294478›Full record

ArticleThe EMBO journal2019

Senataxin homologue Sen1 is required for efficient termination of RNA polymerase III transcription.

Julieta Rivosecchi, Marc Larochelle, Camille Teste, Frédéric Grenier, Amélie Malapert, Emiliano P Ricci, Pascal Bernard, François Bachand, Vincent Vanoosthuyse

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. ΔNp63-Senataxin circuit controls keratinocyte differentiation by promoting the transcriptional termination of epidermal genes.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Julieta RivosecchiLaboratoire de Biologie et Modélisation de la Cellule, Université de Lyon, CNRS, UMR 5239, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Marc LarochelleDépartement de Biochimie, Université de Sherbrooke, Sherbrooke, QC, Canada.
Camille TesteLaboratoire de Biologie et Modélisation de la Cellule, Université de Lyon, CNRS, UMR 5239, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Frédéric GrenierDépartement de Biochimie, Université de Sherbrooke, Sherbrooke, QC, Canada.
Amélie MalapertLaboratoire de Biologie et Modélisation de la Cellule, Université de Lyon, CNRS, UMR 5239, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Emiliano P RicciLaboratoire de Biologie et Modélisation de la Cellule, Université de Lyon, CNRS, UMR 5239, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Pascal BernardLaboratoire de Biologie et Modélisation de la Cellule, Université de Lyon, CNRS, UMR 5239, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.ORCID 0000-0003-2732-9685
François BachandDépartement de Biochimie, Université de Sherbrooke, Sherbrooke, QC, Canada.
Vincent VanoosthuyseLaboratoire de Biologie et Modélisation de la Cellule, Université de Lyon, CNRS, UMR 5239, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.ORCID 0000-0002-4416-1557
Université Claude Bernard Lyon 1 · FRUniversité de Sherbrooke · CA

Funding

Agence Nationale de la Recherche (ANR) ANR-15-CE12-0002-01Agence Nationale de la Recherche (ANR) CHX11_TRACCFondation ARC pour la Recherche sur le Cancer (ARC) PJA 20151203343Gouvernement du Canada|Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2017-05482Ligue Contre le Cancer, comité du Rhône PPE 2016-2018
6 · The paper itself

Abstract

R-loop disassembly by the human helicase Senataxin contributes to genome integrity and to proper transcription termination at a subset of RNA polymerase II genes. Whether Senataxin also contributes to transcription termination at other classes of genes has remained unclear. Here, we show that Sen1, one of two fission yeast homologues of Senataxin, promotes efficient termination of RNA polymerase III (RNAP3) transcription in vivo. In the absence of Sen1, RNAP3 accumulates downstream of RNAP3-transcribed genes and produces long exosome-sensitive 3'-extended transcripts. Importantly, neither of these defects was affected by the removal of R-loops. The finding that Sen1 acts as an ancillary factor for RNAP3 transcription termination in vivo challenges the pre-existing view that RNAP3 terminates transcription autonomously. We propose that Sen1 is a cofactor for transcription termination that has been co-opted by different RNA polymerases in the course of evolution.

Indexed as

DNA HelicasesGene Expression Regulation, FungalRNA HelicasesRNA Polymerase IIIRNA, TransferSchizosaccharomycesTranscription Termination, GeneticDNA HelicasesRNA HelicasesRNA Polymerase IIIRNA, Transfersen1 protein, S pombeR-loopsRNA polymerase IIISenataxintranscription termination

Identifiers

PMID31294478
PMCPMC6694214
OpenAlexW2960799597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.